159 related articles for article (PubMed ID: 16488541)
1. Low molecular weight species of tau in Alzheimer's disease are dependent on tau phosphorylation sites but not on delayed post-mortem delay in tissue processing.
Santpere G; Puig B; Ferrer I
Neurosci Lett; 2006 May; 399(1-2):106-10. PubMed ID: 16488541
[TBL] [Abstract][Full Text] [Related]
2. Individual and regional variations of phospho-tau species in progressive supranuclear palsy.
Puig B; Rey MJ; Ferrer I
Acta Neuropathol; 2005 Sep; 110(3):261-8. PubMed ID: 15973541
[TBL] [Abstract][Full Text] [Related]
3. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
[TBL] [Abstract][Full Text] [Related]
4. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein.
Porzig R; Singer D; Hoffmann R
Biochem Biophys Res Commun; 2007 Jun; 358(2):644-9. PubMed ID: 17499212
[TBL] [Abstract][Full Text] [Related]
6. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R
Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
8. Molecular aging of tau: disulfide-independent aggregation and non-enzymatic degradation in vitro and in vivo.
Watanabe A; Hong WK; Dohmae N; Takio K; Morishima-Kawashima M; Ihara Y
J Neurochem; 2004 Sep; 90(6):1302-11. PubMed ID: 15341514
[TBL] [Abstract][Full Text] [Related]
9. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
10. TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue.
Barrachina M; Castaño E; Ferrer I
Neurochem Int; 2006 Aug; 49(3):276-84. PubMed ID: 16522342
[TBL] [Abstract][Full Text] [Related]
11. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
12. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.
von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E
Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555
[TBL] [Abstract][Full Text] [Related]
13. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
14. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.
Fischer D; Mukrasch MD; Biernat J; Bibow S; Blackledge M; Griesinger C; Mandelkow E; Zweckstetter M
Biochemistry; 2009 Oct; 48(42):10047-55. PubMed ID: 19769346
[TBL] [Abstract][Full Text] [Related]
16. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
Avila J
FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
[TBL] [Abstract][Full Text] [Related]
17. X-ray structure of the PHF core C-terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer's disease.
Sevcik J; Skrabana R; Dvorsky R; Csokova N; Iqbal K; Novak M
FEBS Lett; 2007 Dec; 581(30):5872-8. PubMed ID: 18061582
[TBL] [Abstract][Full Text] [Related]
18. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology.
Julien C; Tremblay C; Bendjelloul F; Phivilay A; Coulombe MA; Emond V; Calon F
J Neurosci Res; 2008 Aug; 86(10):2292-302. PubMed ID: 18338803
[TBL] [Abstract][Full Text] [Related]
19. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
Kaiser E; Schönknecht P; Thomann PA; Hunt A; Schröder J
Neurosci Lett; 2007 May; 417(2):193-5. PubMed ID: 17408854
[TBL] [Abstract][Full Text] [Related]
20. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
